skip nav
  Home | About CDC | Press Room | A-Z Index | Contact Us
spacer
CDC Centers for Disease Control and Prevention Home Page
CDC en Español
Search:  
CDC Home > HIV/AIDSTopics > Statistics and Surveillance > Reports > Reported CD4+ T-Lymphocyte Results for Adults and Adolescents with HIV/AIDS—33 States, 2005
spacer
spacer spacer
spacer
 
Skip Nav spacer
spacer
Table 7. Estimated numbers of adults and adolescents with HIV infection and those with AIDS at the end of 2004, by selected characteristics and lowest CD4 count—33 states with confidential name-based HIV infection reporting
spacer
spacer
View PDF PDF icon

  HIV infection
CD4 count, cells/µLa AIDS
Total
No.
200–350 >350 No CD4 count Total No.b
No. (%) No. (%) No. (%)
Sexc
Male 18,354 (12.5) 47,869 (32.6) 80,430 (54.8) 146,653 187,093
Female 7,528 (12.0) 20,655 (32.8) 34,796 (55.2) 62,978 61,726
Age as of end of year (yrs)
13–14 9 (1.3) 70 (9.9) 629 (88.8) 708 528
15–24 1,230 (9.9) 3,201 (25.7) 8,043 (64.5) 12,474 4,559
25–34 5,540 (11.8) 14,875 (31.6) 26,709 (56.7) 47,123 29,745
35–44 10,161 (12.5) 27,629 (34.1) 43,329 (53.4) 81,119 98,480
45–54 6,550 (13.0) 17,024 (33.9) 26,624 (53.0) 50,199 82,017
55–64 1,911 (13.3) 4,703 (32.9) 7,700 (53.8) 14,313 26,353
≥65 482 (13.0) 1,023 (27.6) 2,195 (59.3) 3,700 7,137
Transmission categoryc
Male adult or adolescent
Male-to-male sexual contact 11,921 (12.9) 31,135 (33.6) 49,643 (53.6) 92,699 106,220
Injection drug use 2,687 (12.2) 7,348 (33.3) 12,029 (54.5) 22,063 39,676
Male-to-male sexual contact and injection drug use 1,307 (14.2) 3,835 (41.7) 4,044 (44.0) 9,187 14,137
Heterosexual contactd 2,228 (10.6) 5,098 (24.4) 13,608 (65.0) 20,934 23,633
Othere 211 (11.9) 453 (25.6) 1,106 (62.5) 1,770 3,427
Female adult or adolescent
Injection drug use 1,862 (12.9) 5,157 (35.8) 7,374 (51.2) 14,394 19,198
Heterosexual contactd 5,534 (11.8) 15,117 (32.1) 26,383 (56.1) 47,034 40,093
Othere 131 (8.4) 381 (24.6) 1,038 (67.0) 1,550 2,435
Race/ethnicity
White, not Hispanic 10,320 (14.3) 28,565 (39.7) 33,117 (46.0) 72,002 84,666
Black, not Hispanic 11,340 (11.1) 30,102 (29.3) 61,181 (59.6) 102,623 114,537
Hispanic 3,695 (11.9) 8,763 (28.3) 18,511 (59.8) 30,969 46,232
Asian/Pacific Islander 198 (15.5) 357 (28.0) 720 (56.5) 1,275 1,404
American Indian/Alaska Native 166 (16.2) 396 (38.7) 462 (45.1) 1,024 960
Unknown 163 (9.3) 342 (19.6) 1,238 (71.1) 1,743 1,021
Totalf 25,881 (12.3) 68,525 (32.7) 115,229 (55.0) 209,635 248,820
Note. In this table, all living persons from the 33 states with confidential name-based reporting are categorized as having HIV infection or AIDS. The term HIV infection (rather than HIV without AIDS) is used here to refer to persons with HIV infection with no evidence of AIDS, regardless of time (i.e., not restricted to 12 months after HIV diagnosis).
These numbers do not represent actual cases in persons with a diagnosis of HIV infection or AIDS. Rather, these numbers are point estimates of case counts that have been adjusted for reporting delays and for redistribution of cases in persons initially reported without an identified risk factor. The estimates have not been adjusted for incomplete reporting.
Since 2000, the following states have had laws or regulations requiring confidential name-based HIV infection reporting: Alabama, Alaska, Arizona, Arkansas, Colorado, Florida, Idaho, Indiana, Iowa, Kansas, Louisiana, Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, West Virginia, Wisconsin, and Wyoming. Since July 1997, Florida has had confidential name-based HIV infection reporting for new diagnoses only.
Based on data received through June 2005; includes persons who were reported as alive or whose vital status was missing or unknown, as of December 31, 2004.
a When only CD4 percentage was available, a CD4 count was interpreted.
b Because row totals were calculated independently of the row values, the values in each row may not sum to the row total.
c Excludes persons of unknown sex.
d With person at high risk or with a diagnosis of HIV infection or AIDS.
e Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or identified.
f Because column totals were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Last Modified: March 14, 2006
Last Reviewed: March 14, 2006
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

 

spacer
spacer
spacer
spacer
  Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
spacer
spacer
spacer Safer, Healthier People
spacer
Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov.
spacer USA.gov: The U.S. Government's Official Web PortalDHHS Department of Health
and Human Services